Skip to main content

Table 5 Comparison of sensitivity and specificity of previously published panels with values obtained for this new panel

From: A novel DNA methylation panel accurately detects colorectal cancer independently of molecular pathway

Panels

Sensitivity (%)

Specificity (%)

AUC

Accuracy

Specimen type

Methods

References

NGFR; SEPT9; TMEFF2

NA

NA

0.890

NA

Tissue

qMSP

[39]

NGFR; SEPT9; TMEFF2; bisDNA

0.790

NA

Plasma

APC; MGMT; RASSF2A; Wif-1

86.5

92.1

0.927

89.2

Plasma

MSP

[14]

SFRP2; RASSF2a

75.0

89.4

NA

NA

Stool

COBRA, Hi-SA

[40]

BMP3; NDRG4; TFPI2; Vimentin

78.0

85.0

0.880

91.2

Stool

QuARTS

[41]

HLTF; HPP1; MLH1

NA

NA

NA

NA

Plasma

qMSP

[42]

DCC; UNC5C

82.0

NA

NA

NA

Tissue

qMSP

[43]

HPP1; MGMT; SFRP2

93.7

77.1

NA

NA

Stool

MSP

[36]

IGFBP3; miR137

95.5

90.5

NA

86.0

Tissue

Bisulfite pyrosequencing

[44]

CNRIP1; FBN1; INA; MAL; SNCA; SPG20b

94.0

98.0

0.984

95.5

Tissue

qMSP

[45]

CMTM3; MDFI; SSTR2

81.0

91.0

0.920

NA

Tissue

Bisulfite pyrosequencing

[46]

MGMT; RASSF1A; SEPT9

96.6

74.0

0.970

90.8

Tissue

qMSP

  1. COBRA combined bisulfite restriction analysis, Hi-SA high-sensitivity assay for bisulfite DNA, NA not available for the panel of genes, QuARTS quantitative allele-specific real-time target and signal amplification
  2. a Also detects gastric cancer
  3. b Co-methylation of two out of six genes